Enliven Therapeutics Inc. (ELVN)
NASDAQ: ELVN
· Real-Time Price · USD
23.07
1.16 (5.29%)
At close: Jun 16, 2025, 3:59 PM
24.24
5.07%
After-hours: Jun 16, 2025, 05:10 PM EDT
5.29% (1D)
| Bid | 21.91 |
| Market Cap | 1.13B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -94.83M |
| EPS (ttm) | -1.92 |
| PE Ratio (ttm) | -12.02 |
| Forward PE | -7.83 |
| Analyst | Buy |
| Ask | 25.92 |
| Volume | 1,096,454 |
| Avg. Volume (20D) | 398,847 |
| Open | 23.05 |
| Previous Close | 21.91 |
| Day's Range | 22.21 - 24.11 |
| 52-Week Range | 13.30 - 30.03 |
| Beta | 0.95 |
About ELVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ELVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ELVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 days ago
+11.44%
Enliven Therapeutics shares are trading higher. Th...
Unlock content with
Pro Subscription
1 month ago
-10.41%
Enliven Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.